The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I look at the balance sheet ... 27m shares issued
Then I multiply by the share price.
To get the current value of about 3m give or take.
Can be verified by looking at the documents on the company's own website.
Don't rely on Yahoo's bots.
Have a look...
https://www.next-chemx.com/investor-information/corporate-documents/
Pony,
The Texas pilot plant and Bolivian pilot plant are separate bits of kit, so funds are needed to build it, from the first RNS...
"The plant will test circa 1,000 litres of each specific brine, with an overall 20,000 litre trial run size,..."
That's the Texas bit.
"... allowing a customised NCX DLE commercial system to be assembled (in modular form) and placed on site for field testing."
That's the Bolivian bit.
I agree with you though, the need for additional funding wasn't clear in the first RNS. And the first million doesn't seem to go very far. The Bolivian end could cost much more !
But ultimately it's an insignificant amount if this comes off.
A couple of months and we'll know if it is going to work and how much it'll cost. Whatever that is, as it stands we will only have to find 50% of it.
It'll be interesting to see what comes of the discussions with other non-Bolivian lithium developers.
I don't think it is cyfalafwr.
CLON is seriously undervalued for the potential.
I think it's more that there is no need to rush in - still to go is test plant building, testing and then results - at that point it gets exciting as we would expect to move to on-location testing, and then things get serious (albeit further funding required etc).
No problem steward1.
I've just done a side-by-side comparison, nothing bad in my view and slightly better if anything. The finer detail was always to be worked out.
More detail as you say. Plus the addition of a 12 month lock in for half of the first tranche - that's good to see.
As to the option to invest £250k in CLON, it seems that 30 days meant working days, that gives them until tomorrow so it might still transpire.
The same has said many times over the last month, and selling at any profit has been proven to be the right call.
Even selling at a loss may have well have been right call for anyone who has made money by reinvesting elsewhere.
Of course, news could arrive anytime. But I would not criticise sellers - they may have done much better than holders over the last 6 weeks and may continue to do so for a while yet, news tomorrow or in 2 months, who knows.
Each to their own.
Not forgotten MrT, but the only project we can say with any certainty is moving forward is Bolivia.
Sasanof and Ghana not may not make further progress and I'm certainly not assuming they will - Ghana will be a nice bonus if it does.
Sasanof, I'm not sure about, I don't want another massive solution for a wild cat - but fund raising for a drill on the back of progress in Bolivia (and a much higher SP) would mean less dilution and it might make it worth the risk.
I think you're under shooting there ...
An agreement of the type described is worth what ?
Balancing risk and potential - at this early stage, let's say £25m.
Using the fully diluted 4.4bn share base, that's still an SP of well over half a penny.
I think this is a very conservative calculation, and so an easy 3 to 4 bag on positive news. The market may value it much higher - particularly if positive news is supported by an announcement from YLB and/or the Bolivian government.
The only decision left is whether you believe terms will be agreed and signed.
Just sharing my view - no intention to ramp, this is still a risky investment (but aren't they all) - agreement may not be reached.
In fairness, he never said an announcement expected within 30 days, just that agreement would be finalised. We expected that to be announced, but perhaps there's is no requirement to announce it straight away. And maybe the announcement will contain details of further progress on other fronts, perhaps with Bolivian authorities, along with the agreement.
Good question RachelD, since it's for a Bolivia only venture I would expect registration to be in Bolivia - I would think it would be a condition of the licence. Keep the taxation within Bolivia, subject to Bolivian law etc.
It's the joint venture company that will hold the exclusivity rights. So CLON will have 50% by virtue of its 50% holding.
CLON will also have shares in the partnering company so will benefit more widely to some degree.
Sharebell, I'm quite chilled thanks. I just don't think anyone should characterise the additional shares as 'not that big'.
The number of additional shares is very significant as can be seen by dampening effect the sell off is having on the very enthusiastic buying. Once we are clear, any good news will be free to fully impact the price.
And the longer we wait for that good news the better as it gives more time for the overhang to clear.
GLA
Because they are not speculators and gamblers like us mere mortals. They are invited to back a sure thing - they're in profit and they'll cash out so they can redeploy their capital to the next client.
Or something like that.